ブレイン・マシン・インターフェース＆ニューロモデュレーション：影響評価、ベンダの位置づけ＆市場予測 2019-2030年
Brain Machine Interfaces & Neuromodulation
BMI（ブレイン・マシン・インターフェース）とニューロモデュレーションは、様々な垂直市場での課題を数多く解決できる革新的なソリューションを生み出す力を持っている新しいデバイスです。このレポ... もっと見る
サマリー
BMI（ブレイン・マシン・インターフェース）とニューロモデュレーションは、様々な垂直市場での課題を数多く解決できる革新的なソリューションを生み出す力を持っている新しいデバイスです。このレポートはBMIとニューロモデュレーション市場を調査し、使用事例の分析や、デバイス製造と技術プロバイダの市場機会について言及しています。
市場ダイナミクス：使用事例とBMIの採用
-
蝸牛インプラント
-
ADAS向けBMI
-
スマートホームコントロール
-
集中/疲労モニタリング
ベンチマーク産業別の予測
Overview
Juniper’s BMI (Brain Machine Interfaces) & Neuromodulation research provides a detailed overview of how this emerging field is evolving, with new devices being leveraged to create innovative solutions to solve numerous issues across several different verticals. The research analyses different use cases and opportunities for device manufacturers and technology providers across the following verticals:
-
Medical
-
Automotive
-
Consumer
-
Industrial
-
Military
The research investigates the potential impact that BMIs will have on these sectors; assessing their disruptive potential and future impact on existing markets against a set of key metrics. It includes insightful player analysis, alongside key recommendations for stakeholders in the industry to identify revenue opportunities and inform strategic planning.
The research includes:
-
Market Trends & Opportunities (PDF)
-
10-Year Market Sizing & Forecast Spreadsheet (Excel)
-
Market Dynamics: Investigates key use cases for BMI across multiple verticals; assessing BMI deployment viability in each area, including:
-
Cochlear implants
-
BMI for ADAS
-
Smart home control
-
Concentration/fatigue monitoring
-
BMI Impact Assessment: Covers use cases across verticals; analysing which BMIs can transform, against the following metrics:
-
User Impact
-
Regulatory Barriers
-
Technological Clarity
-
Cost Barriers
-
Quality of User Experience
-
Ecosystem Readiness
-
Benchmark Industry Forecasts: Market segment forecasts for key BMI areas, including:
-
Medical
-
Automotive
-
Consumer
-
Industrial
-
Military
-
Juniper Disruptors & Challengers Quadrant: 24 leading BMI vendors compared, scored and positioned on Juniper’s Disruptors & Challengers Quadrant; providing benchmark player analysis.
-
What is the revenue opportunity for BMI & Neuromodulation devices?
-
What are the best uses for BMI deployment?
-
Which vendors are leading the BMI market?
-
At what point will BMI become viable outside strictly medical use cases?
-
What interface technologies will flourish in the BMI market?
Case Studied: Össur
Included in Disruptors & Challengers Quadrant: Advanced Bionics, Advanced Brain Monitoring, BIOS, Bitbrain, BrainCo, Cochlear Limited, Cognixion, Dreem, Emotiv, Flow Neuroscience, Halo Neuroscience, InteraXon, MED-EL, Neurable, Neuralink, NeuroPace, Neuros Medical, NeuroSky, Nextmind, Paradromics, Synchron, Thync, Versus.
Mentioned: Amazon, Boring Company, BrainGate, FDA (Food and Drug Administration), Johnson & Johnson, NHS (National Health Service), NICE (National Institute for Health and Care Excellence), Nissan, Ottobock, Renault, SEAT, SecondSight, SmartCap Technologies, Sonova Group, SpaceX, Tesla, US DARPA (Defense Advanced Research Projects Agency), Valve.
Data & Interactive Forecast
Juniper’s BMI & Neuromodulation forecast suite includes:
-
10-year benchmark forecasts for key metrics by 8 key regions and 8 country level splits including:
-
Canada
-
China
-
Germany
-
Japan
-
South Korea
-
Sweden
-
UK
-
US
-
BMI forecast, including devices in use, shipments and revenues across the following segments:
-
Consumer
-
Automotive
-
Medical
-
Industrial
-
Military
-
Interactive Scenario tool allowing the user the ability to manipulate Juniper’s data for 15 different metrics.
-
Access to the full set of forecast data of 47 tables and over 10,200 datapoints.
Juniper Research’s highly granular interactive Excels enable clients to manipulate Juniper’s forecast data and charts to test their own assumptions and compare markets side by side in customised charts and tables. IFxls greatly increase clients’ ability to both understand a particular market and to integrate their own views into the model.
ページTOPに戻る
目次
Table of Contents
1. Key Takeaways & Strategic Recommendations
1.1 Brain Machine Interfaces Key Takeaways . 5
Figure 1.1: Key Forecast Findings, 2030 . 5
1.2 Strategic Recommendations . 6
2. Demystifying Brain Machine Interfaces
2.1 Introduction . 8
2.1.1 Definition & BMI Goals . 8
Figure 2.1: Principal Goals of BMI Research . 8
2.1.2 BMIs & Neuromodulation . 9
2.1.3 BMI Milestones . 9
Figure 2.2: BMI Research Milestones . 9
2.2 Categorising BMIs . 10
Figure 2.3: Categories of BMI & Technologies Utilised . 10
2.2.1 Invasive BMIs . 11
Figure 2.4: Deep Brain Stimulation Explanation . 12
i. Challenges to Use . 12
ii. Future Outlook . 12
2.2.2 Non-Invasive BMI . 12
Figure 2.5: Origins of MEG Signals . 13
ii. Challenges to Use . 14
iii. Future Outlook . 14
2.2.3 Neuromodulation . 14
i. Challenges to Use . 15
ii. Future Outlook . 16
2.3 BMIs in Use Today . 16
2.4 BMI Future Outlook . 17
Figure 2.6: Juniper Phased Evolution: BMIs . 17
i. Phase 1: Medical & Military Research . 17
ii. Phase 2: First Medical Deployments. 17
iii. Phase 3: Consumer & Automotive Research . 17
Figure 2.7: Automotive BMI Example . 18
iv. Phase 4: Mainstream Consumer Deployments . 18
v. Phase 5: Mainstream Automotive Deployments . 18
vi. Phase 6: AI Integration . 18
2.5 BMI Investment Landscape . 19
Figure 2.8: Recent High-Profile Investments in BMI Vendors . 19
3. BMIs: Use Cases, Impact Assessments & Market Trends
3.1 BMI Use Case Analysis . 21
3.1.1 Medical . 21
i. Cochlear Implants . 21
Figure 3.1: Diagram of a Cochlear Implant . 21
Figure 3.2: ABI Implant Diagram . 22
ii. Visual Prosthetics . 23
Figure 3.3: Argus II Diagram . 23
iii. Brain Rehabilitation . 24
Figure 3.4: Deep Brain Stimulation Diagram . 24
iv. Limb Prostheses . 25
Case Study: Ossur . 26
v. Sleep Modification Tools . 27
3.1.2 Automotive . 28
i. ADAS. 28
Figure 3.5: Example of ADAS Systems. 29
Figure 3.6: Number of Registered Consumer Vehicles with ADAS Installed (m),
2018-2026, Split by 8 Key Regions . 29
3.1.3 Consumer . 31
i. Gaming & VR (Virtual Reality) . 31
Figure 3.7: Number of VR Headsets, Installed Base per Annum (m), Split by 8
Key Regions . 31
ii. Smart Home Control . 32
iii. Guided Meditation . 33
Figure 3.8: Muse 2 Headband . 33
3.1.4 Industrial/Military . 34
i. Concentration Monitoring/Safety Devices . 34
ii. Military Use Cases . 35
3.2 BMI Impact Assessment . 37
Table 3.9: BMI Impact Assessment Heatmap . 37
Table 3.10: BMI Impact Assessment Heatmap Key . 38
Table 3.11: Impact Assessment Methodology . 39
Figure 3.12: Comparison of Impact of Top Five Ranked BMI Use Cases . 40
Table 3.13: Top 5 Use Case Ranking Based on Combined Scores . 40
3.2.1 Impact Assessment Commentary . 41
i. Short Term Impact . 41
ii. EEG Technology . 41
iii. Growing Consumer Enthusiasm . 41
3.3 Key Constraints . 41
3.3.1 Stage of Technological Development . 41
3.3.2 Regulation . 42
3.3.3 Consumer Attitudes . 42
4. BMI Player Analysis
4.1 BMI Disruptors & Challengers Analysis . 44
Figure 4.1: Juniper BMI Disruptors & Challengers Quadrant . 44
4.1.1 Disruptors . 45
Table 4.2: Cochlear Ltd Financial Highlights ($m) 2016-2018 . 45
Figure 4.3: Cochlear’s Nucleus Cochlear Implant . 45
Figure 4.4: MED-EL Synchrony Cochlear Implant . 47
Figure 4.5: NeuroSky MindWave Mobile 2 Headset . 48
Table 4.6: NeuroPace Funding Rounds . 49
4.1.2 Catalyst Players . 51
Figure 4.7: Flow Device . 51
Figure 4.8: Versus App Exercises . 52
Table 4.9: InteraXon Funding Rounds . 52
Table 4.10: Halo Neuroscience Funding Rounds . 53
Figure 4.11: Halo Sport 2 Neuropriming Headphones . 53
Table 4.12: Dreem Funding Rounds . 54
4.1.3 Embryonic Players . 55
Table 4.13: BIOS Funding Rounds . 55
5. BMI Market Forecasts
5.1 Introduction . 61
5.2 Methodology & Assumptions . 61
Figure 5.1: BMI Forecast Methodology . 62
5.3 BMI Market Forecasts . 63
5.3.1 Number of BMI Devices in Use . 63
Figure 5.2: Total Number of BMI Devices in Use (m), Split by 8 Key Regions, 2019-2030 . 63
Table 5.3: Total Number of BMI Devices in Use (m), Split by 8 Key Regions, 2019-2030 . 64
Table 5.4: Total Number of BMI Devices in Use (m), Split by Segment, 2019-2030 . 64
5.3.2 Number of BMI Device Shipments . 65
Figure 5.5: Total Number of BMI Device Shipments Per Annum (m), Split by 8
Key Regions, 2019-2030 . 65
Table 5.6: Total Number of BMI Device Shipments Per Annum (m), Split by 8 Key
Regions, 2019-2030 . 66
Table 5.7: Total Number of BMI Device Shipments Per Annum (m), Split by Segment, 2019-2030 . 66
5.3.3 Total Hardware Sales Revenue for BMI Devices. 67
Figure 5.8: Total Hardware Sales Revenue for BMI Devices Per Annum ($m),
Split by 8 Key Regions, 2019-2030 . 67
Table 5.9: Total Hardware Sales Revenue for BMI Devices Per Annum ($m), Split
by 8 Key Regions, 2019-2030 . 68
Table 5.10: Total Hardware Sales Revenue for BMI Devices Per Annum ($m),
Split by Segment, 2019-2030. 68
ページTOPに戻る
Summary
BMI（ブレイン・マシン・インターフェース）とニューロモデュレーションは、様々な垂直市場での課題を数多く解決できる革新的なソリューションを生み出す力を持っている新しいデバイスです。このレポートはBMIとニューロモデュレーション市場を調査し、使用事例の分析や、デバイス製造と技術プロバイダの市場機会について言及しています。
市場ダイナミクス：使用事例とBMIの採用
-
蝸牛インプラント
-
ADAS向けBMI
-
スマートホームコントロール
-
集中/疲労モニタリング
ベンチマーク産業別の予測
Overview
Juniper’s BMI (Brain Machine Interfaces) & Neuromodulation research provides a detailed overview of how this emerging field is evolving, with new devices being leveraged to create innovative solutions to solve numerous issues across several different verticals. The research analyses different use cases and opportunities for device manufacturers and technology providers across the following verticals:
-
Medical
-
Automotive
-
Consumer
-
Industrial
-
Military
The research investigates the potential impact that BMIs will have on these sectors; assessing their disruptive potential and future impact on existing markets against a set of key metrics. It includes insightful player analysis, alongside key recommendations for stakeholders in the industry to identify revenue opportunities and inform strategic planning.
The research includes:
-
Market Trends & Opportunities (PDF)
-
10-Year Market Sizing & Forecast Spreadsheet (Excel)
-
Market Dynamics: Investigates key use cases for BMI across multiple verticals; assessing BMI deployment viability in each area, including:
-
Cochlear implants
-
BMI for ADAS
-
Smart home control
-
Concentration/fatigue monitoring
-
BMI Impact Assessment: Covers use cases across verticals; analysing which BMIs can transform, against the following metrics:
-
User Impact
-
Regulatory Barriers
-
Technological Clarity
-
Cost Barriers
-
Quality of User Experience
-
Ecosystem Readiness
-
Benchmark Industry Forecasts: Market segment forecasts for key BMI areas, including:
-
Medical
-
Automotive
-
Consumer
-
Industrial
-
Military
-
Juniper Disruptors & Challengers Quadrant: 24 leading BMI vendors compared, scored and positioned on Juniper’s Disruptors & Challengers Quadrant; providing benchmark player analysis.
-
What is the revenue opportunity for BMI & Neuromodulation devices?
-
What are the best uses for BMI deployment?
-
Which vendors are leading the BMI market?
-
At what point will BMI become viable outside strictly medical use cases?
-
What interface technologies will flourish in the BMI market?
Case Studied: Össur
Included in Disruptors & Challengers Quadrant: Advanced Bionics, Advanced Brain Monitoring, BIOS, Bitbrain, BrainCo, Cochlear Limited, Cognixion, Dreem, Emotiv, Flow Neuroscience, Halo Neuroscience, InteraXon, MED-EL, Neurable, Neuralink, NeuroPace, Neuros Medical, NeuroSky, Nextmind, Paradromics, Synchron, Thync, Versus.
Mentioned: Amazon, Boring Company, BrainGate, FDA (Food and Drug Administration), Johnson & Johnson, NHS (National Health Service), NICE (National Institute for Health and Care Excellence), Nissan, Ottobock, Renault, SEAT, SecondSight, SmartCap Technologies, Sonova Group, SpaceX, Tesla, US DARPA (Defense Advanced Research Projects Agency), Valve.
Data & Interactive Forecast
Juniper’s BMI & Neuromodulation forecast suite includes:
-
10-year benchmark forecasts for key metrics by 8 key regions and 8 country level splits including:
-
Canada
-
China
-
Germany
-
Japan
-
South Korea
-
Sweden
-
UK
-
US
-
BMI forecast, including devices in use, shipments and revenues across the following segments:
-
Consumer
-
Automotive
-
Medical
-
Industrial
-
Military
-
Interactive Scenario tool allowing the user the ability to manipulate Juniper’s data for 15 different metrics.
-
Access to the full set of forecast data of 47 tables and over 10,200 datapoints.
Juniper Research’s highly granular interactive Excels enable clients to manipulate Juniper’s forecast data and charts to test their own assumptions and compare markets side by side in customised charts and tables. IFxls greatly increase clients’ ability to both understand a particular market and to integrate their own views into the model.
ページTOPに戻る
Table of Contents
Table of Contents
1. Key Takeaways & Strategic Recommendations
1.1 Brain Machine Interfaces Key Takeaways . 5
Figure 1.1: Key Forecast Findings, 2030 . 5
1.2 Strategic Recommendations . 6
2. Demystifying Brain Machine Interfaces
2.1 Introduction . 8
2.1.1 Definition & BMI Goals . 8
Figure 2.1: Principal Goals of BMI Research . 8
2.1.2 BMIs & Neuromodulation . 9
2.1.3 BMI Milestones . 9
Figure 2.2: BMI Research Milestones . 9
2.2 Categorising BMIs . 10
Figure 2.3: Categories of BMI & Technologies Utilised . 10
2.2.1 Invasive BMIs . 11
Figure 2.4: Deep Brain Stimulation Explanation . 12
i. Challenges to Use . 12
ii. Future Outlook . 12
2.2.2 Non-Invasive BMI . 12
Figure 2.5: Origins of MEG Signals . 13
ii. Challenges to Use . 14
iii. Future Outlook . 14
2.2.3 Neuromodulation . 14
i. Challenges to Use . 15
ii. Future Outlook . 16
2.3 BMIs in Use Today . 16
2.4 BMI Future Outlook . 17
Figure 2.6: Juniper Phased Evolution: BMIs . 17
i. Phase 1: Medical & Military Research . 17
ii. Phase 2: First Medical Deployments. 17
iii. Phase 3: Consumer & Automotive Research . 17
Figure 2.7: Automotive BMI Example . 18
iv. Phase 4: Mainstream Consumer Deployments . 18
v. Phase 5: Mainstream Automotive Deployments . 18
vi. Phase 6: AI Integration . 18
2.5 BMI Investment Landscape . 19
Figure 2.8: Recent High-Profile Investments in BMI Vendors . 19
3. BMIs: Use Cases, Impact Assessments & Market Trends
3.1 BMI Use Case Analysis . 21
3.1.1 Medical . 21
i. Cochlear Implants . 21
Figure 3.1: Diagram of a Cochlear Implant . 21
Figure 3.2: ABI Implant Diagram . 22
ii. Visual Prosthetics . 23
Figure 3.3: Argus II Diagram . 23
iii. Brain Rehabilitation . 24
Figure 3.4: Deep Brain Stimulation Diagram . 24
iv. Limb Prostheses . 25
Case Study: Ossur . 26
v. Sleep Modification Tools . 27
3.1.2 Automotive . 28
i. ADAS. 28
Figure 3.5: Example of ADAS Systems. 29
Figure 3.6: Number of Registered Consumer Vehicles with ADAS Installed (m),
2018-2026, Split by 8 Key Regions . 29
3.1.3 Consumer . 31
i. Gaming & VR (Virtual Reality) . 31
Figure 3.7: Number of VR Headsets, Installed Base per Annum (m), Split by 8
Key Regions . 31
ii. Smart Home Control . 32
iii. Guided Meditation . 33
Figure 3.8: Muse 2 Headband . 33
3.1.4 Industrial/Military . 34
i. Concentration Monitoring/Safety Devices . 34
ii. Military Use Cases . 35
3.2 BMI Impact Assessment . 37
Table 3.9: BMI Impact Assessment Heatmap . 37
Table 3.10: BMI Impact Assessment Heatmap Key . 38
Table 3.11: Impact Assessment Methodology . 39
Figure 3.12: Comparison of Impact of Top Five Ranked BMI Use Cases . 40
Table 3.13: Top 5 Use Case Ranking Based on Combined Scores . 40
3.2.1 Impact Assessment Commentary . 41
i. Short Term Impact . 41
ii. EEG Technology . 41
iii. Growing Consumer Enthusiasm . 41
3.3 Key Constraints . 41
3.3.1 Stage of Technological Development . 41
3.3.2 Regulation . 42
3.3.3 Consumer Attitudes . 42
4. BMI Player Analysis
4.1 BMI Disruptors & Challengers Analysis . 44
Figure 4.1: Juniper BMI Disruptors & Challengers Quadrant . 44
4.1.1 Disruptors . 45
Table 4.2: Cochlear Ltd Financial Highlights ($m) 2016-2018 . 45
Figure 4.3: Cochlear’s Nucleus Cochlear Implant . 45
Figure 4.4: MED-EL Synchrony Cochlear Implant . 47
Figure 4.5: NeuroSky MindWave Mobile 2 Headset . 48
Table 4.6: NeuroPace Funding Rounds . 49
4.1.2 Catalyst Players . 51
Figure 4.7: Flow Device . 51
Figure 4.8: Versus App Exercises . 52
Table 4.9: InteraXon Funding Rounds . 52
Table 4.10: Halo Neuroscience Funding Rounds . 53
Figure 4.11: Halo Sport 2 Neuropriming Headphones . 53
Table 4.12: Dreem Funding Rounds . 54
4.1.3 Embryonic Players . 55
Table 4.13: BIOS Funding Rounds . 55
5. BMI Market Forecasts
5.1 Introduction . 61
5.2 Methodology & Assumptions . 61
Figure 5.1: BMI Forecast Methodology . 62
5.3 BMI Market Forecasts . 63
5.3.1 Number of BMI Devices in Use . 63
Figure 5.2: Total Number of BMI Devices in Use (m), Split by 8 Key Regions, 2019-2030 . 63
Table 5.3: Total Number of BMI Devices in Use (m), Split by 8 Key Regions, 2019-2030 . 64
Table 5.4: Total Number of BMI Devices in Use (m), Split by Segment, 2019-2030 . 64
5.3.2 Number of BMI Device Shipments . 65
Figure 5.5: Total Number of BMI Device Shipments Per Annum (m), Split by 8
Key Regions, 2019-2030 . 65
Table 5.6: Total Number of BMI Device Shipments Per Annum (m), Split by 8 Key
Regions, 2019-2030 . 66
Table 5.7: Total Number of BMI Device Shipments Per Annum (m), Split by Segment, 2019-2030 . 66
5.3.3 Total Hardware Sales Revenue for BMI Devices. 67
Figure 5.8: Total Hardware Sales Revenue for BMI Devices Per Annum ($m),
Split by 8 Key Regions, 2019-2030 . 67
Table 5.9: Total Hardware Sales Revenue for BMI Devices Per Annum ($m), Split
by 8 Key Regions, 2019-2030 . 68
Table 5.10: Total Hardware Sales Revenue for BMI Devices Per Annum ($m),
Split by Segment, 2019-2030. 68
ページTOPに戻る
Juniper Research 社の最新刊レポート
本レポートと同じKEY WORD（interfaces）の最新刊レポート
よくあるご質問
Juniper Research社はどのような調査会社ですか?
ジュニパーリサーチ社(Juniper
Research)は2001年の創立以来、モバイルとデジタル技術を専門に調査・出版事... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
